Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Eosinophilic gastritis affects the stomach with dense eosinophilic infiltration and lacks approved long-term treatments, highlighting a significant unmet medical need.

• Why it matters: The disease's rarity and diagnostic complexity delay effective management, and current therapies offer limited success or are unsuitable for sustained use, underscoring the need for better solutions.
• What they did: Researchers reviewed the disease's pathophysiology, diagnostic criteria, and current treatment limitations, emphasizing the role of food antigens and immune dysregulation involving interleukins 4 and 13.
• The result: Ongoing clinical trials of biologic therapies may improve diagnosis and treatment, potentially transforming care for patients with this challenging, under-addressed condition.